Promising heart disease drug fails in trial
Doctors had expected the experimental drug, which lowers a common heart attack risk factor, to save lives.
An experimental heart disease medicine that was expected to help has failed in a trial. The drug made no difference for patients.
Key points
- An experimental drug that lowers a heart attack risk factor showed no benefit.
- Doctors had expected it to save lives.
Read the original reporting
Summarized with AI from the sources above and reviewed before publishing.
